Quick Answer
SELLAS Life Sciences Group, Inc. reported Total Assets of $78.34 million for fiscal year 2025.
SELLAS Life Sciences Group, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $78.34M | +303.2% |
| 2024 | $19.43M | +212.5% |
| 2023 | $6.22M | -70.3% |
| 2022 | $20.94M | -20.3% |
| 2021 | $26.27M | -42.9% |
| 2020 | $46.05M | +177.3% |
| 2019 | $16.61M | -1.8% |
| 2018 | $16.91M | -49.5% |
| 2017 | $33.53M | +422.2% |
| 2016 | $6.42M | -92.2% |
| 2015 | $82.14M | +2.1% |
| 2014 | $80.49M | -8.5% |
| 2013 | $87.98M | +60.0% |
| 2012 | $54.99M | +77.6% |
| 2011 | $30.97M | +314.2% |
| 2010 | $7.48M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $51.55M | +94.5% | +59.6% |
| June 30, 2025 | $32.30M | +113.7% | -7.6% |
| March 31, 2025 | $34.96M | +43.1% | +79.9% |
| December 31, 2024 | $19.43M | +212.5% | -26.7% |
| September 30, 2024 | $26.50M | +227.8% | +75.3% |
| June 30, 2024 | $15.12M | -18.6% | -38.1% |
| March 31, 2024 | $24.43M | -16.0% | +292.9% |
| December 31, 2023 | $6.22M | -70.3% | -23.1% |
- SELLAS Life Sciences Group, Inc. showed an increase of +303.2% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, SELLAS Life Sciences Group, Inc.’s total assets has grown by 948.0% (from $7.48 million to $78.34 million).
- The most recent figure is from SELLAS Life Sciences Group, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: